9 results
·
20ms
·
Sources: EU EUDAMED, US FDA
Filters
Regulation: Us FDA
×
Langston dual lumen catheter
FDA 510(k)
FDA Class 2
·Cardiovascular
FRANKLIN SPORTS, INC.
FDA registration
FRANKLIN SPORTS, INC.·2 products·🇺🇸 United States
FULLY AUTOMATIC WIRELESS BLOOD PRESSURE WRIST MONITOR
FDA 510(k)
FDA Class 2
·Cardiovascular
SEER LIGHT COMPACT DIGITAL HOLTER RECORDER
FDA 510(k)
FDA Class 2
·Cardiovascular
M2A-MAGNUM MOD HD SZ 44MM
FDA Adverse Event
Injury
·ZIMMER BIOMET, INC.·Product code KWA·March 20, 2019
STRYKEFLOW2 WITH DISPOSABLE TIP (6BX)
FDA Adverse Event
Malfunction
·STRYKER ENDOSCOPY-SAN JOSE·Product code LJH·November 3, 2014
LIFEVEST WCD 4000 SYSTEM
FDA Adverse Event
Malfunction
·ZOLL LIFECOR CORPORATION·Product code MVK·August 17, 2011
JUVEDERM ULTRA PLUS XC TSK US
FDA Adverse Event
Injury
·ALLERGAN·Product code LMH·July 9, 2013
Brand Name: SenTiva" Product Name: VNS Therapy" SenTiva", Model 1000 Model/Catalog Number: 1000 Software Version: NA Product Description: The LivaNova VNS Therapy" System, used for Vagus Nerve Stimulation (VNS), consists of an implantable VNS Therapy generator, lead, and external programming system used to change stimulation settings. The generator is an implantable, multi-programmable pulse generator that delivers electrical signals to the vagus nerve through the lead. The generator is housed in a hermetically sealed titanium case and is powered by a single battery. Electrical signals are transmitted from the generator to the vagus nerve by the lead. The lead and the generator make up the implantable portion of the VNS Therapy System. The VNS Therapy Programming System includes a computer pre-installed with VNS Therapy programming software and a programming wand. The physician uses the programming system to read and change generator settings. The Model 1000 Generator was commercially approved for distribution in the U.S. on October 3, 2017 via PMA P970003/S210. Component: The LivaNova VNS Therapy" System, used for Vagus Nerve Stimulation (VNS).
FDA Enforcement
Class II
·Ongoing·LivaNova USA, Inc.·February 5, 2025